Evaluating Risk Factors for Clinical Failure Among Tigecycline-Treated Patients
Multiple comorbidities, BSI, and higher Pitt bacteremia scores are associated with increased risk of clinical failure in tigecycline-treated patients. These results suggest clinicians should consider alternatives to tigecycline for patients with these risk factors. When administering tigecycline, vigilant monitoring is indicated to manage potential clinical failures.
Authors
- Chunfu Huang (ORCID: https://orcid.org/0000-0002-8887-257X)
- Wang‐Huei Sheng (ORCID: https://orcid.org/0000-0002-5605-7853)
- Yu‐Chung Chuang (ORCID: https://orcid.org/0000-0003-3094-8276)
- Jia‐Ling Yang
Institutions
- National Taiwan University Hospital (TW)
Publication Details
- Journal
- Infection and Drug Resistance
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/idr.s496809
- Citations
- 1
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.17
Funders
- Ministry of Health and Welfare
- Ministry of Science and Technology, Taiwan
- National Taiwan University Hospital
- National Taiwan University